The present invention relates to the use of inhibitors of the CD95 ligand/receptor system for the manufacture of a medicament for the treatment of neurological disorders or injuries in a mammal, particularly for the treatment of spinal cord injury, more particularly for the treatment of paraplegia.

 
Web www.patentalert.com

< Composition and Method for Selective Cytostasis

< Inducible plasmid vector encoding tgf-beta and use thereof

> Compositions and methods for inhibiting inflammation of vessel walls and formation of neointimal hyperplasia

> Calpains as targets for inhibition of prion propagation
~ 00296